Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval August 20, 2020 Syncing FDA-CMS Decisions Elusive for Now, Official Says April 7, 2016 Norlase Gets CE Mark for Leaf Laser July 22, 2020
